Build the Career You Envision.

 

 

 

 

Please note we have a new talent acquisition system. If you have previously applied, no need to apply again. If you would like to apply for a new position, please create a new profile. 

I am looking for a career… 

 

Our comprehensive benefits program… 

 

Competitive Compensation

Stock Purchase Plans

401(k) Retirement Plan

Paid Time Off

Health/Welfare Insurance

Continuing Education (CME/CNE)

“MEDNAX has created a family atmosphere among our department, and in doing so, has created the best team of coders out there. We support each other in both our professional and personal endeavors. We feel comfortable going to our team leads and supervisors with ideas and suggestions that can make our company better. When you feel like a company is listening to you, you’re willing to go that extra mile. MEDNAX creates and facilitates these feelings every day.” 

Lauren Dennis

Coding Specialist, Knoxville, TN

“As an employee of MEDNAX for fifteen years, I have always been proud of my colleagues’ passion and dedication. MEDNAX is truly a family of health care professionals who care about each other and work together to provide the best care and service to those we serve.”

Kelly K. Hunt

Office Manager, Savannah, GA

Latest MEDNAX News & Views

The Mind Matters Too: Postpartum Depression Screening & Referral in the NICU







mind

Left untreated, postpartum depression (PPD) is not only harmful to a mother, but can lead to long-term detrimental effects for an infant and family as well. The key to optimal care is early identification and treatment, and it takes a team effort to identify women in need of mental health support after giving birth. MEDNAX-affiliated neonatologist Rebecca Mischel, MD, and her co-authors agree. They published findings of their quality improvement initiative in a recent edition of Neonatal Network called Postpartum Mood Disorders Screening in the NICU.

read more

Cardiovascular Safety of Stimulant Medications for ADHD







untitled-design-53

Guest blog by Jeffrey W. Skimming, MD, and Jorge McCormack, MD

Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral problem that is often treated with stimulants such as methylphenidate and mixed amphetamine salts. Despite their efficacy and long history of use, concerns regarding their potential for adverse cardiovascular effects in children and adolescents with ADHD regularly receive ongoing public attention.

read more